n(6)-carboxymethyllysine has been researched along with Scleroderma, Systemic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbate, R; Bartoli, F; Basta, G; Castellani, S; Conforti, ML; De Caterina, R; Del Rosso, A; Generini, S; Guiducci, S; Kaloudi, O; Livi, R; Matucci-Cerinic, M; Miniati, I; Perfetto, F; Pignone, A | 1 |
1 other study(ies) available for n(6)-carboxymethyllysine and Scleroderma, Systemic
| Article | Year |
|---|---|
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis.
Topics: Adult; Aged; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Microcirculation; Microscopic Angioscopy; Middle Aged; Scleroderma, Systemic; Tunica Intima; Tunica Media | 2007 |